BILLERICA, Mass.--(BUSINESS WIRE)--EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, today announced that the Beijing Higher Court, Beijing, China has affirmed a lower court’s decision against RephiLe Bioscience for copying and selling purification cartridges for lab water systems, infringing on patents owned by EMD Millipore. The Court determined that RephiLe’s accused products fall into the protection scope of EMD Millipore’s patent. The decision upholds the permanent injunction against RephiLe to discontinue making, selling and offering to sell the infringing products. The decision also confirmed the award of damages to EMD Millipore originally set by the lower court.
Help employers find you! Check out all the jobs and post your resume.
